Class Action

GOLO’s Release Supplement

Class Action

GOLO’s Release Supplement


Case Name (Date)

Bubak et al v. GOLO, LLC
21-cv-492, E.D. Cal.
(March 2021)


Product/Service

GOLO’s Release Supplement


Allegations

Implying that the supplement mitigates and prevents diabetes, heart disease, and Alzheimer’s disease by claiming that it is “the Natural Solution to Insulin Resistance”

Misleadingly marketing the supplement as “Clinically Proven” when the company relies on pilot studies that it paid for and that have not been peer reviewed or published in legitimate scientific publications


Status

Pending



The Latest

Filters

Fisher Investments

Ad Alert

Fisher Investments

Unearthing the fees that Fisher charges but doesn’t disclose in some of its TV ads.


Show More